GlassScriptPhysician profile
Donald Martinelli
NPI 1710926001
$1,540.70
in general payments reported to CMS, 2019-2025
13 companies · $197 in 2025
The $197 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $12.12 · 2022: $339 · 2023: $484 · 2024: $508 · 2025: $197.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,189.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $609.41 | 2022-2023 | Arexvy, Shingrix |
| Novo Nordisk INC | $142.01 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Tandem Diabetes Care, INC. | $138.17 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Phathom Pharmaceuticals, INC. | $130.40 | 2024 | Voquezna |
| Gilead Sciences, INC. | $115.99 | 2024 | Epclusa |
| Sunovion Pharmaceuticals INC. | $109.51 | 2022 | |
| Ge Healthcare | $104.19 | 2022 | |
| Exact Sciences Corporation | $57.23 | 2024 | Cologuard Collection Kit |
| Otsuka America Pharmaceutical, INC. | $48.61 | 2024 | Rexulti |
| Astrazeneca Pharmaceuticals LP | $31.04 | 2024 | Farxiga |
| Pfizer INC. | $22.73 | 2025 | |
| Shield Therapeutics INC | $19.29 | 2025 | |
| Lilly USA, LLC | $12.12 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Martinelli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.